MYOMO INC (MYO)
US62857J2015 - Common Stock
MYO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. MYO has a great financial health rating, but its profitability evaluates not so good. MYO is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
MYO had negative earnings in the past year.
MYO had a negative operating cash flow in the past year.
In the past 5 years MYO always reported negative net income.
In the past 5 years MYO always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of MYO (-55.88%) is worse than 72.02% of its industry peers.
MYO has a worse Return On Equity (-90.64%) than 66.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -55.88% | ||
| ROE | -90.64% | ||
| ROIC | N/A |
ROA(3y)-72.06%
ROA(5y)-94.76%
ROE(3y)-110.23%
ROE(5y)-213.46%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 68.51%, MYO is in the better half of the industry, outperforming 75.65% of the companies in the same industry.
In the last couple of years the Gross Margin of MYO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MYO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.4%
GM growth 5Y-0.49%
2. Health
2.1 Basic Checks
MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYO has more shares outstanding
The number of shares outstanding for MYO has been increased compared to 5 years ago.
MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
MYO has an Altman-Z score of 2.07. This is not the best score and indicates that MYO is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.07, MYO is in the better half of the industry, outperforming 61.14% of the companies in the same industry.
There is no outstanding debt for MYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.07 |
ROIC/WACCN/A
WACC9.6%
2.3 Liquidity
A Current Ratio of 2.49 indicates that MYO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.49, MYO is doing worse than 63.73% of the companies in the same industry.
A Quick Ratio of 2.16 indicates that MYO has no problem at all paying its short term obligations.
MYO's Quick ratio of 2.16 is in line compared to the rest of the industry. MYO outperforms 43.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.49 | ||
| Quick Ratio | 2.16 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 77.87% over the past year.
Looking at the last year, MYO shows a very strong growth in Revenue. The Revenue has grown by 23.70%.
The Revenue has been growing by 51.09% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)77.87%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q9.09%
Revenue 1Y (TTM)23.7%
Revenue growth 3Y36.39%
Revenue growth 5Y51.09%
Revenue growth Q2Q8.95%
3.2 Future
The Earnings Per Share is expected to grow by 26.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, MYO will show a very strong growth in Revenue. The Revenue will grow by 26.87% on average per year.
EPS Next Y23.05%
EPS Next 2Y34.89%
EPS Next 3YN/A
EPS Next 5Y26.4%
Revenue Next Year37.78%
Revenue Next 2Y34.51%
Revenue Next 3YN/A
Revenue Next 5Y26.87%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MYO's earnings are expected to grow with 34.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.89%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for MYO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MYOMO INC
NYSEARCA:MYO (5/17/2024, 7:15:26 PM)
After market: 3.6401 0 (0%)3.64
-0.04 (-1.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap104.83M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -55.88% | ||
| ROE | -90.64% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.51% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.49 | ||
| Quick Ratio | 2.16 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)77.87%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y23.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)23.7%
Revenue growth 3Y36.39%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y